Demis Hassabis
Hassabis has not shown a public longevity portfolio here. The only supported signal is narrower: he links DeepMind-scale AI to disease work through Isomorphic Labs.
Dimension breakdown
This score rates longevity commitment only. The role tags above — scientist, investor, and the rest — say what this person is; we don't score those separately.
Evidence is still sparse for this hero. Scores are shown with low-confidence warnings until more source material is harvested.
Future vision
0.0/ 10
The evidence does not show a concrete or durable public vision for ending aging, reversing biological decline, or materially extending healthy human lifespan. The X profile references working on AGI and solving disease, but this is too broad to count as a longevity-specific future vision.
high confidence
Scientific impact
4.0/ 10
Scientific impact appears applicable, but the provided evidence lacks citation metrics, authored papers, clinical trials, or independent/primary corroboration. The only source is a self-published X profile claiming Nobel Laureate status and leadership roles connected to DeepMind and Isomorphic Labs, which can indicate claimed scientific relevance but cannot justify a high result score under the independence gate.
low confidence
Capital deployed
1.0/ 10
The evidence shows no disclosed longevity-directed investments, donations, philanthropy, or funding amounts. The only potentially relevant signal is a self-published X bio noting leadership of Google DeepMind and Isomorphic Labs, but it does not document personal capital deployment or independently corroborated longevity funding.
low confidence
Strategic taste
5.0/ 10
The evidence shows a coherent strategy of using frontier AI/AGI-oriented systems for science and disease, including leadership of Google DeepMind and Isomorphic Labs. That supports some strategic taste because the thesis is platform-level and translational, but the provided evidence is thin, self-published, and lacks timing, counterfactual detail, specific longevity outcomes, investment history, or proof that these bets opened paths others missed.
low confidence
Field creation
2.0/ 10
Field creation applies, but the provided evidence gives almost no corroborated longevity-specific field-building activity. The only positive signal is a self-published X bio claiming co-founder/CEO of Google DeepMind and work on disease via Isomorphic Labs, but this is not independent corroboration and is not clearly longevity-field creation in the supplied evidence.
low confidence
Bravery and conviction
0.0/ 10
The dimension is applicable, but the provided evidence contains no concrete public risk-taking, contrarian longevity stance, career sacrifice, sustained conviction under criticism, large personal bet, or self-experimentation related to longevity.
low confidence
Multiplier effect
3.0/ 10
The dimension applies, but the provided evidence is very thin and self-published only. Hassabis claims leadership of Google DeepMind and involvement with Isomorphic Labs, which suggests potential platform-level leverage in AI and disease research, but there is no independent evidence here of attracting talent, capital, collaborators, policy attention, public legitimacy, or follow-on projects.
low confidence
Vision
Destination
No canonical quotes yet.
Path
No canonical quotes yet.
Strategy
Use advanced AI, including AGI-oriented systems, to solve disease and advance fundamental scientific understanding.
The available evidence supports a strategy centered on applying frontier AI to major scientific problems rather than a visible investment or philanthropy portfolio [S1]. Hassabis frames his work at Google DeepMind around AGI, suggesting a platform-level approach to intelligence systems [S1]. He also explicitly connects Isomorphic Labs with solving disease, indicating a translational life-science focus [S1]. No specific investments, donations, geography, stage preference, time horizon, or external collaborator network is supported by the provided evidence [S1].
UnknownUnknownAGIDisease SolvingAI ScienceFundamental Reality
Notable bets
Portfolio
Investments
No public rows yet.
Donations
No public rows yet.
Organizations founded
No public rows yet.
Scientific output
h-index-
Citations-
Papers0
Trials0
No public rows yet.
Connections
Companies
No public rows yet.